Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

December 09, 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

November 06, 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

October 07, 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

July 15, 2022

Medtronic Recalls Batteries in Some HeartWare VAD Systems

News Daily News

Medtronic Recalls Batteries in Some HeartWare VAD Systems

June 23, 2022

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

News Daily News

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

April 29, 2022

New HF Guidelines Stress Four Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 01, 2022

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

February 22, 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

February 02, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.